14-74292598-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005050.4(ABCD4):​c.981C>A​(p.Leu327Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.347 in 1,613,252 control chromosomes in the GnomAD database, including 100,815 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7523 hom., cov: 32)
Exomes 𝑓: 0.35 ( 93292 hom. )

Consequence

ABCD4
NM_005050.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.91

Publications

35 publications found
Variant links:
Genes affected
ABCD4 (HGNC:68): (ATP binding cassette subfamily D member 4) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ALD subfamily, which is involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs in the organelle. All known peroxisomal ABC transporters are half transporters which require a partner half transporter molecule to form a functional homodimeric or heterodimeric transporter. The function of this peroxisomal membrane protein is unknown. However, it is speculated that it may function as a heterodimer for another peroxisomal ABC transporter and, therefore, may modify the adrenoleukodystrophy phenotype. It may also play a role in the process of peroxisome biogenesis. Alternative splicing results in several protein-coding and non-protein-coding variants. [provided by RefSeq, Jul 2017]
ABCD4 Gene-Disease associations (from GenCC):
  • methylmalonic acidemia with homocystinuria, type cblJ
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 14-74292598-G-T is Benign according to our data. Variant chr14-74292598-G-T is described in ClinVar as [Benign]. Clinvar id is 259622.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.91 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.366 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCD4NM_005050.4 linkc.981C>A p.Leu327Leu synonymous_variant Exon 10 of 19 ENST00000356924.9 NP_005041.1 O14678A0A024R6B9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCD4ENST00000356924.9 linkc.981C>A p.Leu327Leu synonymous_variant Exon 10 of 19 1 NM_005050.4 ENSP00000349396.4 O14678

Frequencies

GnomAD3 genomes
AF:
0.303
AC:
45894
AN:
151700
Hom.:
7532
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.169
Gnomad AMI
AF:
0.468
Gnomad AMR
AF:
0.303
Gnomad ASJ
AF:
0.443
Gnomad EAS
AF:
0.253
Gnomad SAS
AF:
0.361
Gnomad FIN
AF:
0.310
Gnomad MID
AF:
0.564
Gnomad NFE
AF:
0.370
Gnomad OTH
AF:
0.359
GnomAD2 exomes
AF:
0.324
AC:
81342
AN:
250768
AF XY:
0.338
show subpopulations
Gnomad AFR exome
AF:
0.160
Gnomad AMR exome
AF:
0.222
Gnomad ASJ exome
AF:
0.437
Gnomad EAS exome
AF:
0.242
Gnomad FIN exome
AF:
0.310
Gnomad NFE exome
AF:
0.371
Gnomad OTH exome
AF:
0.372
GnomAD4 exome
AF:
0.352
AC:
514442
AN:
1461432
Hom.:
93292
Cov.:
48
AF XY:
0.355
AC XY:
258297
AN XY:
726988
show subpopulations
African (AFR)
AF:
0.161
AC:
5374
AN:
33478
American (AMR)
AF:
0.230
AC:
10283
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.444
AC:
11599
AN:
26130
East Asian (EAS)
AF:
0.242
AC:
9595
AN:
39686
South Asian (SAS)
AF:
0.371
AC:
32005
AN:
86212
European-Finnish (FIN)
AF:
0.314
AC:
16760
AN:
53360
Middle Eastern (MID)
AF:
0.524
AC:
3019
AN:
5766
European-Non Finnish (NFE)
AF:
0.364
AC:
404182
AN:
1111716
Other (OTH)
AF:
0.358
AC:
21625
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
20104
40208
60311
80415
100519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12584
25168
37752
50336
62920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.302
AC:
45886
AN:
151820
Hom.:
7523
Cov.:
32
AF XY:
0.300
AC XY:
22284
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.169
AC:
6975
AN:
41388
American (AMR)
AF:
0.303
AC:
4623
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.443
AC:
1536
AN:
3470
East Asian (EAS)
AF:
0.253
AC:
1297
AN:
5134
South Asian (SAS)
AF:
0.360
AC:
1727
AN:
4796
European-Finnish (FIN)
AF:
0.310
AC:
3277
AN:
10556
Middle Eastern (MID)
AF:
0.568
AC:
166
AN:
292
European-Non Finnish (NFE)
AF:
0.370
AC:
25103
AN:
67902
Other (OTH)
AF:
0.359
AC:
756
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1622
3243
4865
6486
8108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.355
Hom.:
23144
Bravo
AF:
0.293
Asia WGS
AF:
0.309
AC:
1072
AN:
3478
EpiCase
AF:
0.396
EpiControl
AF:
0.404

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Methylmalonic acidemia with homocystinuria, type cblJ Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Dec 02, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
9.1
DANN
Benign
0.75
PhyloP100
1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4148078; hg19: chr14-74759301; COSMIC: COSV53991086; COSMIC: COSV53991086; API